Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease

OBJECTIVE: To study the aggravation of clinical symptoms after discontinuation of metal chelating agent therapy in Wilson's disease (WD) patients, analyze the causes of aggravation, and observe the prognosis. METHODS: 40 WD patients (cerebral type 30 cases and hepatic type 10 cases) who stopped...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiangxue, Liao, Jian, Liu, Yinjie, Qin, Haolin, Xiao, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498091/
https://www.ncbi.nlm.nih.gov/pubmed/37491953
http://dx.doi.org/10.1002/brb3.3170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498091/
https://www.ncbi.nlm.nih.gov/pubmed/37491953
http://dx.doi.org/10.1002/brb3.3170

Ejemplares similares